Trials / Completed
CompletedNCT00426972
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites
A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 148 (estimated)
- Sponsor
- Renovo · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This trial will assess the effects of Zesteem (estradiol) on the healing of split thickness skin graft donor sites in patients aged 18-85 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | estradiol (Zesteem) |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-07-01
- Completion
- 2008-10-01
- First posted
- 2007-01-25
- Last updated
- 2009-08-28
Locations
30 sites across 4 countries: Germany, Latvia, Russia, United Kingdom
Source: ClinicalTrials.gov record NCT00426972. Inclusion in this directory is not an endorsement.